Oxford Biodynamics rolls out EpiSwitch PSE prostate cancer test in US
Developed based on the company’s unique EpiSwitch 3D genomics platform, the EpiSwitch Prostate Screening (PSE) test runs alongside…
Mission Bio introduces Tapestri scMRD AML Multiomics Assay
27 Sep 23Tapestri is a single-cell measurable residual disease (MRD) test intended to provide deep genotypic and immunophenotypic insights into…
Galen gets FDA De Novo grant and clearance for Galen ES Robotic System
27 Sep 23The world’s first such robotic platform is intended to ease ear, nose, and throat surgical procedures, including instrument…
Abyrx secures expanded FDA approval for MONTAGE settable bone putty
27 Sep 23The FDA approval expands the surgical applications of MONTAGE, a unique mouldable bone putty that was previously approved…
Saluda Medical Receives FDA Approval for Evoke System MRI Labeling
27 Sep 23Patients implanted with the Evoke System now eligible for full-body MRI scans
Moon Surgical Announces First Clinical Cases in the US Using Maestro System
27 Sep 23Surgeons at Baptist Health successfully perform weight loss surgery using a revolutionary surgical robotics system.
HoneyNaps secures FDA approval for SOMNUM to detect sleep disorders
26 Sep 23SOMNUM is a sleep disorders analysis software, developed using explainable medical AI (XAI) technology and integrates the latest…
Enovis to acquire orthopaedic implant producer LimaCorporate for €800m
26 Sep 23The acquisition of Lima is expected to strengthen Enovis’ reconstructive business and help expand the latter’s global presence…
Adela secures $48m financing to advance MRD monitoring products
26 Sep 23Adela intends to use the proceeds from the financing to advance its technology platform and commercialise its first…
Profound Medical wins FDA 510(k) clearance for TULSA-PRO Thermal Boost
26 Sep 23Thermal Boost is the firm’s first FDA-cleared TULSA AI module which enables predictable, tailored ablation at the prostate…